Yüklüyor......
How I treat newly diagnosed chronic phase CML
The progress made in the understanding of chronic myeloid leukemia (CML) since the recognition of a common chromosomal abnormality to the introduction of ever more effective tyrosine kinase inhibitors is unprecedented in cancer. The expected survival for patients diagnosed with CML today, if properl...
Kaydedildi:
| Yayımlandı: | Blood |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4916560/ https://ncbi.nlm.nih.gov/pubmed/22613793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-03-378919 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|